Retension Pharmaceuticals, Inc.
Cena
Finančné výkazy zatiaľ nemáme
Výkazy tejto firmy zatiaľ nemáme. Cenu a jej vývoj vidíte vyššie.
Fundamenty
Načítavam kľúčové čísla…
Insideri, analytici a ľudia
Všetky obchody a zmenyNačítavam insiderov, analytikov a názory…
Co se právě děje
AI souhrnO spoločnosti
Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The Company operates as a single operating and reportable segment focused on the development of treatments for hypertension and cardiovascular disease. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.
Český popis pripravujeme.
- Zamestnanci
- 12
- Krajina
- USA
- Dáta od
- 9. 10. 2026